Results 111 to 120 of about 3,927,451 (224)

Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark

open access: yes, 2014
OBJECTIVE: Prenatal and postnatal RhD prophylaxis reduces the risk of RhD immunization in pregnancies of RhD-negative women. Based on the result from prenatal screening for the fetal RHD gene, prenatal RhD prophylaxis in Denmark is targeted to RhD ...
Jakobsen, T R   +30 more
core   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Forecasting the rate of hemolytic disease of the fetus and newborn in the United States based on recent trends in prehospital transfusion

open access: yesTransfusion, EarlyView.
Abstract Background As prehospital transfusion becomes more common in the United States (US), cases of hemolytic disease of the fetus and newborn (HDFN) might increase. This study forecasted the number of HDFN cases in 2029 resulting from RhD‐positive prehospital transfusions. Study Design and Methods A regression was performed on the number of females
Adnan S. Syed   +6 more
wiley   +1 more source

Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping

open access: yes, 2014
ObjectivesFetal RHD screening programs that aim to reduce unnecessary antenatal anti-D prophylaxis are being introduced into clinical practice. Strategies to manage women serologically typed as Rhesus D negative who have maternal RHD variants are needed.
Ochoa-Garay, Gorka   +8 more
core   +1 more source

Discordant prenatal and postnatal RhD typing caused by a novel RHD frameshift variant (c.540del; p.Leu181CysfsTer48) in Swedish individuals

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Non‐invasive prenatal testing (NIPT) for fetal RHD genotyping is widely used to guide anti‐D prophylaxis, but discrepancies between predicted fetal RhD status and postnatal serological typing can occur due to variant RHD alleles.
Ahlam Badri   +4 more
wiley   +1 more source

Identification of a novel high‐prevalence red blood cell antigen on junctional adhesion molecule‐A defines a new blood group system

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Availability of new technologies has accelerated the pace of blood group discovery, with nine of 48 known systems being discovered in the past 5 years alone, and yet uncharacterized antigens remain. This study involved investigations of samples from a female patient presenting with a moderate strength pan‐reactive ...
Tosti J. Mankelow   +7 more
wiley   +1 more source

Optimization of platelet concentrate inventory management using a simple standardized decision‐support model: A retrospective study from a Regional Blood Center

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Platelet concentrates (PCs) are difficult to manage because of their short shelf‐life and variable clinical demand. The aim of this study was to evaluate the impact of a modified platelet inventory management strategy at a Regional Blood Donation and Treatment Center on product utilization and expiration‐related ...
Anna Lizoń   +2 more
wiley   +1 more source

Comparative detection of red cell alloantibodies by solid‐phase red cell adherence and column agglutination technology in routine pre‐transfusion testing

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Detection of clinically significant alloantibodies (CSAs), particularly weak or weakly reactive antibodies, remains challenging with conventional agglutination methods and may contribute to delayed haemolytic transfusion reactions (DHTRs).
Rasika Dhawan Setia   +4 more
wiley   +1 more source

Fetal RHD genotyping by maternal plasma analysis [PDF]

open access: yes, 2019
Determination of the fetal RhD typing using free fetal DNA in maternal plasma, is beginning to gain widespread acceptance in Europe and may allow genetic analysis without the use of invasive techniques.
Ζournatzi-Koiou, Vassiliki   +2 more
core  

Evaluation of two real-time multiplex PCR screening assays detecting fetal RHD in plasma from RhD negative women to ascertain the requirement for antenatal RhD prophylaxis

open access: yes, 2010
OBJECTIVE: To evaluate two different multiplex real-time PCR assays detecting fetal RHD for screening of RhD negative women in relation to antenatal RhD prophylaxis.METHODS: We designed a duplex assay for the detection of RHD exon 7 and 10 and a triplex ...
Frederik Banch Clausen   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy